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Human platelets containing granule-bound [%]serotonin were permeabilized, equilibrated at 0’ C with ATP 
and with various Caz+ buffers and guanine nucleotides, and then incubated at 25” C with or without a stimu- 
latory agonist. Ca*+ alone induced the ATP-dependent secretion of [14C]serotonin (50:; at a pCa of 5.1) 
but the sensitivity of secretrion to CaZ+ was greatly enhanced by guanine nucleotides [6-fold by 100pM 
GTP, lOO-fold by 100pM guanyl-S-y1 imidodiphosphate and > SOO-fold by 100pM guanosine 5’-O-(3-thio- 
triphosphate)] or by stimulatory agonists (lo-fold by 2 units thrombin/ml and 4-fold by 1 PM I-O-octadecyl- 
2-0-acetyl-sn-glyceryl-3-phosphorylcholine). When both GTP and a stimulatory agonist were added, they 
had synergistic effects on secretion. Cyclic GMP and GMP acted similarly to GTP. The effects of all these 
guanine nucleotides were inhibited by guanosine 5’-0-(2_thiodiphosphate), whereas those of stimulatory 
agonists were not. Our results demonstrate the presence in platelets of guanine nucleotide-dependent and 
independent mechanisms regulating the sensitivity of secretrion to Ca’+, 
Guanine nucleotide Calcium 
1. INTRODUCTION 
Abundant evidence has accumulated to indicate 
that Ca2+ plays an important role as an in- 
tracellular mediator of the secretory responses of 
the blood platelet. Thus, Ca2+ ionophores 
stimulate platelet degranulation [ 1,2], platelets 
permeabilized by high-voltage electric discharges 
secrete granule contents in response to added Ca2+ 
[3,4] and studies with the fluorescent indicator, 
quin2, have demonstrated increases in [Ca2+free] in 
response to stimuli such as thrombin [5] and 
platelet-activating factor [6]. In platelets [7], as in 
Abbreviations: pCa, - logKaZ+&; Gpp(NH)p, gua- 
nyl-5 ’ -yl imidodiphosphate; GTPyS, guanosine 5 ( -O- 
(3-thiotriphosphate); GDP,&, guanosine 5’-O- 
(2-thiodiphosphate); 1-octadecyl-2-acetyl-G-3-PC, l-O- 
octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine 
(synthetic platelet-activating factor) 
Throw&n Secretion Platelet 
other cells [8,9], Ca2+ mobilization by 
physiological stimuli appears to be closely 
associated with the receptor-activated hydrolysis 
of phosphatidylinositol 4,Sbisphosphate to 
1 ,Zdiacylglycerol and inositol 1,4,5trisphosphate. 
In some cell types, the latter product has been 
directly implicated in the release of Ca2+ from the 
endoplasmic reticulum into the cytosol [ 10,111. 
The former also acts as a signal molecule by enhan- 
cing the Ca2+ sensitivity of protein kinase C [12], 
which in platelets phosphorylates a 47-kDa protein 
in a reaction closely associated with the secretory 
process [ 13- 151. Experiments with intact platelets 
have indeed suggested that Ca2+ acts synergistical- 
ly with diacylglycerol to promote secretion [16] 
and this has been demonstrated irectly in studies 
with permeabilized platelets [17-191. In the latter 
system, thrombin increased the sensitivity of the 
secretion of serotonin to Ca2+ by lo-fold, an effect 
that was associated with stimulation of 
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diacylglycerol formation and enhanced phos- 
phorylation of P47 [ 191. The preservation of 
these receptor-mediated effects in permeabilized 
platelets permits investigation of low-M, factors in- 
volved in receptor action. Here, we have in- 
vestigated the possibility that guanine nucleotides 
may play a role in platelet activation. This study 
was prompted by the observation that the binding 
of agonists to hepatic ai-adrenergic receptors, 
which are linked to Ca’+ mobilization, is regulated 
by guanine nucleotides [20] and a report that incor- 
poration of these nucleotides into mast cells can 
promote secretion of histamine [21]. 
2. MATERIALS AND METHODS 
2.1. Materials 
[side chain-2-‘4C]Serotonin (55 mCi/mmol) was 
from Amersham (Oakville, Ontario). Gpp(NH)p, 
GTPyS and GDP@ were obtained from Boehr- 
inger (Mannheim) and ATP (prepared by 
phosphorylation of adenosine and therefore essen- 
tially GTP-free), GTP, GMP, cyclic GMP and 
Arg*-vasopressin from Sigma (St. Louis, MO). 
Human thrombin (3200 NIH units/mg protein) 
was from Calbiochem-Behring (La Jolla, CA). 
1-Octadecyl-2-acetyl-G-3-PC was a gift from Dr 
H.R. Baumgartner of F. Hoffmann-La Roche 
(Basel) and U-46619 [(1X!+hydroxy-1 la,9a-(epox- 
ymethano)prosta-5Z, 13E-dienoic acid] was pro- 
vided by Dr J.E. Pike of the Upjohn Co. 
(Kalamazoo, MI). 
2.2. Preparation of suspensions of permeabilized 
platelets 
Human platelets in plasma containing ACD an- 
ticoagulant were incubated at 37°C with sufficient 
[‘4C]serotonin to incorporate about 0.05 &i of 
14C/109 platelets. They were then washed and 
finally suspended at l-2 x 109/ml in Ca’+-free 
Tyrode’s solution containing 5 mM l,Cpipera- 
zinediethanesulphonic acid and 0.35% bovine 
serum albumin (final pH 6.5). After addition of 
5 mM Na-EGTA (pH 6.5), 2-ml samples (at 
20-23°C) were placed in a chamber formed by 
stainless-steel ectrodes 0.2 cm apart and subject- 
ed to 10 electric discharges from a 4.5 PF capacitor 
charged at 3 kV. The permeabilized platelets were 
then cooled to 4”C, applied to a column of 
Sepharose CL4B and eluted with a medium (pH 
7.4) containing 12.5 mM MgC12 and the K+ salts of 
glutamic acid (160 mM), Hepes (20 mM), EGTA 
(2.5 mM) and EDTA (2.5 mM) (buffer A). The 
eluate was then diluted with buffer A containing 
ATP to give a final ATP concentration of 5 mM 
and a platelet count of 0.45 x 109/ml. This suspen- 
sion was stored at 0°C and used for up to 2 h. Fur- 
ther details are given in [19]. 
2.3. Incubations 
Samples (80~1) of suspensions of permeabilized 
platelets were mixed with 20 /cl buffer A containing 
additions thought to act at intracellular sites, such 
as CaClz and guanine nucleotides. The CaClz re- 
quired to give particular pCa values was calculated 
as in [22] and the pH of CaClz solutions adjusted 
so that a final pH of 7.4 was obtained. These mix- 
tures were first equilibrated for 15 min at 0°C to 
ensure that additions penetrated the platelets fully 
[ 191. Then, buffer A (1~1) containing any 
stimulatory agonist was added and the final mix- 
tures were incubated for 10 min at 25°C. Incuba- 
tions were usually terminated by addition of 0.5 ml 
of 0.15 M KC1 containing 1.8% (w/v) parafor- 
maldehyde and 6 mM EDTA and the 
[ 14C]serotonin released was determined [ 191. The 
14C in supernatants from samples equilibrated for 
15 min at 0°C with buffer A only (about 5% of 
total platelet r4C) was subtracted in calculation of 
the percentage (R) of platelet [r4C]serotonin re- 
leased by various additions. To determine the 
sensitivity of the secretion of [‘4C]serotonin from 
permeabilized platelets to added Ca2+ buffers, the 
pCa at which release of 50% of the total platelet 
14C occurred was calculated from the linear regres- 
sion of log[R/lOO-R] on pCa. Only values of R 
between 10 and 90% were used. Some incubations 
were terminated by centrifugation without addi- 
tions to determine whether lactate dehydrogenase 
(assayed as in [23]) was released. 
3. RESULTS 
In this study, in which permeabilized platelets 
were equilibrated with GTP-free ATP, Ca2+ 
released 50% of platelet [14C]serotonin at a pCa of 
5.11 + 0.03 (mean + SE from 10 experiments), a 
slightly lower value than observed in [19]. 
However, addition of an optimal dose of thrombin 
(2 units/ml) still increased the sensitivity of the 
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platelets to Ca2+ by about lo-fold to give 50% 
secretion at a pCa of 6.13 f 0.11 (mean f SE from 
8 experiments). Guanine nucleotides exerted ef- 
fects qualitatively similar to those of thrombin, 
causing displacement of the Ca2+ log dose- 
response curve to the left (fig.1). Whereas GTP 
had a maximal effect at 100,~M that was slightly 
weaker than that of thrombin, the metabolically 
stable GTP analogues, Gpp(NH)p and GTPyS, 
were more effective than thrombin when present at 
10 PM or above (fig.2). At 100 ,uM, Gpp(NH)p in- 
creased the Ca2+ sensitivity of the platelets by 
about lOO-fold, though no secretion was observed 
in the absence of added Ca2+ (fig.1,2). This con- 
centration of GTPyS enhanced Ca2+ sensitivity 
>500-fold and caused substantial release of 
[14C]serotonin without added Ca2+ (fig. 1). 
However, addition of a further 10 mM EGTA 
decreased this response, indicating that trace 
amounts of endogenous Ca2+ were required. Other 
experiments howed that 100pM GTPyS did not 
release lactate dehydrogenase from permeabilized 
platelets, indicating that this nucleotide selectively 
promoted the secretion of granule constituents. 
&a 
Fig.1. Effects of guanine nucleotides on the release of 
[14C]serotonin from permeabilized platelets by buffered 
concentrations of Cak. Samples of suspensions of 
permeabilized platelets were equilibrated for 15 min at 
0°C with the indicated Ca’+ buffers and, variously, no 
other additions (O), 100rM GTP (A), 100pM 
Gpp(NH)p (0) or 100 pM GTPrS (v). Thrombin (final 
concentration 2 units/ml) was then added to one group 
of control samples (0) and all were incubated for 
10 min at 25°C. Release of [14C]serotonin was 
measured. Values are means f SE from 3 separate 
experiments. 
0” 
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Fig.2. Effects of different concentrations of guanine 
nucleotides on the sensitivity to CaZf of the secretion of 
[‘4C]serotonin from permeabilized platelets. Experi- 
ments were carried out as for fig.1 but with a range of 
concentrations of GTP (A), Gpp(NH)p (IX) and 
GTPyS (v). The pCu causing release of 50% of platelet 
[r4C]serotonin was calculated (see section 2.3) for each 
guanine nucleotide concentration studied and for 
controls without (0) and with (0) 2 units thrombin/ml. 
Mean values k SE from 3 separate experiments are 
shown. 
Moreover, 1OOpM GTPyS released <2% of the 
14C content of intact platelets labelled with 
[14C]serotonin, when these platelets were isolated 
and incubated in a manner identical to 
permeabilized platelets. This result shows that 
GTPyS acts at intracellular sites. 
The effects of equilibration of permeabilized 
platelets with GTP on the actions of thrombin and 
other agonists were investigated over a wide range 
of pCu values. Low concentrations of GTP (e.g., 
4 ,uM) that alone caused only small increases in the 
release of [14C]serotonin from permeabilized 
platelets, stimulated secretion appreciably more in 
the presence of thrombin, particularly at pCa 
values of 6-7 (fig.3). Determination of the pCu 
values causing secretion of 50% of platelet 
[‘4C]serotonin in 4 experiments of this type showed 
that 4rM GTP caused an increase of 0.09 + 0.05 
(mean f SE) in the absence of thrombin and of 
0.52 k 0.03 (mean ? SE) in the presence of 2 units 
thrombin/ml. Similar synergistic interactions bet- 
ween GTP and thrombin were observed when low 
concentrations of both were used (e.g., table 1, 
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expt.2) or when a weak thrombin stimulus (0.1 
units/ml) was studied in the presence of 1OOpM 
GTP. A high concentration of 1-octadecyl-Zace- 
Fig.3. Synergistic effects of GTP and aggregating agents 
on the sensitivity to Ca2+ of the secretion of 
[‘4C]serotonin from permeabilized platelets. Samples of 
a suspension of permeabilized platelets were equilibrated 
for 15 min at 0°C with the indicated Ca2+ buffers and 
either no guanine nucleotide (open symbols) or 4pM 
GTP (closed symbols). The samples were then incubated 
min at 25°C with, variously, no further additions 
PCs 
are means + SE 
from 3 determinations in the same experiment. 
Table 1 
Effects of GDP@i on the potentiation of [‘4C]serotonin release from permeabilized platelets by guanine nucleotides 
Expt. Additions Release of [‘4C]serotonin (@IO) 
Without GDPBS With 400~M GDP,BS 
1 None 
GTP (4 PM) 
GTP (100 ,uM) 
GPP(NH)P (100 PM) 
GTPyS (10 pM) 
GTPyS (100 /JM) 
Thrombin (2 units/ml) 
Thrombin (2 units/ml) + GTP (4/M) 
I-Octadecyl-2-acetyl-G-3-PC (1 PM) 
I-Octadecyl-2-acetyl-G-3-PC (1 PM) + GTP (4 PM) 
2 None 
GTP (1OpM) 
GMP (10 PM) 
Cyclic GMP (10pM) 
Thrombin (0.2 units/ml) 
Thrombin (0.2 units/ml) + GTP (10pM) 
Thrombin (0.2 units/ml) + GMP (1OyM) 
Thrombin (0.2 units/ml) + cyclic GMP (10pM) 
9*1 
11 * 1 
46 + 4 
85 f 3 
66 f 1 
93 f 2 
66 + 1 
83 + 2 
38 + 5 
61 + 3 
7+0 
20 * 2 
22 k 2 
15 f 2 
19 f 0 
55 f 3 
6Ofl 
58 + 0 
8kl 
6k lb 
14 Y!I 2b 
39 f 4b 
36 f 5b 
80+ lb 
61 + 4 
64 f 5= 
38 + 5 
39 + 5a 
7+1 
9 f Ob 
9+ lb 
10 + 3 
23 k 1 
27 + 2a 
27 f Ob 
30* lb 
a p < 0.05 
bp<0.005 
Samples of suspensions of permeabilized platelets containing [r4C]serotonin were mixed with additions to give a final 
pCu of 6.0 and the guanine nucleotide concentrations indicated. These mixtures were equilibrated for 15 min at 0°C. 
Thrombin or I-octadecyl-2-acetyl-G-3-PC was then added to the samples indicated and all were incubated for 10 min 
at 25°C before measurement of the [r4C]serotonin released. Incubation mixtures contained 3.5 mM ATP (expt.1) or 
4 mM ATP (expt.2). Results are means + SE from 3 determinations in the same experiment. The significance of 
inhibition of the release of [‘4C]serotonin by GDP@ was determined by Student’s t test 
93 
Volume 174, number 1 FEBS LETTERS August 1984 
tyl-G-3-PC (1 PM) increased the sensitivity of the 
secretion of [14C]serotonin to Ca2+ about 4-fold 
(fig.3). Effects almost identical to those of 
1-octadecyl-2-acetyl-G-3-PC were also obtained 
with 0.2 PM Arg’-vasopressin and 10 ,uM U-46619, 
a prostaglandin endoperoxide analogue (not 
shown). Equilibration of permeabilized platelets 
with 4 FM GTP potentiated the effects of all 3 of 
these agonists at least as effectively as it did the ac- 
tion of thrombin (e.g., fig.3). 
The mechanism by which guanine nucleotides 
enhanced secretion was investigated by using 
GDP,& a competitive inhibitor of the interactions 
of GTP with guanine nucleotide-binding proteins 
[24,25]. Simultaneous equilibration with 400 ,vM 
GDP@ almost completely blocked all the actions 
of GTP on permeabilized platelets and roughly 
halved the potentiation of secretion by 100,~M 
Gpp(NH)p or 1OpM GTPyS (table 1, expt.1). A 
weaker inhibition of the effects of 100 FM GTPyS 
was observed, Although GDP@S blocked the 
enhancement of secretion by GTP added prior to 
thrombin or 1-octadecyl-2-acetyl-G-3-PC, it did 
not inhibit the potentiation of secretion caused by 
the latter agonists alone (table 1). This finding sug- 
gests the existence of both guanine nucleotide- 
dependent and independent mechanisms that 
regulate the sensitivity of secretion to Ca2+. 
Low concentrations of GMP and cyclic GMP 
(e.g., 1OpM) were found to exert stimulatory ef- 
fects on the secretion of [‘*C]serotonin in both the 
presence and absence of thrombin that were almost 
identical with those caused by the same concentra- 
tions of GTP (table 1, expt.2). The actions of the 
former guanine nucleotides were also inhibited by 
GDP@. 
4. DISCUSSION 
Our results show that guanine nucleotides, ac- 
ting at one or more intracellular sites, enhance the 
Ca2+ sensitivity of the secretory mechanism of the 
blood platelet. Both with respect o the relative ac- 
tivities of the GTP derivatives tested (GTPyS > 
Gpp(NH)p + GTP) and the inhibition of their ac- 
tions by GDP@& our observations are strongly 
reminiscent of the effects of these compounds on 
the N, and Ni proteins mediating activation and in- 
hibition of adenylate cyclase, respectively 124-281. 
It is therefore probable that a similar guanine 
94 
nucleotide-binding protein with GTP-ase activity 
plays a role in platelet activation. Participation of 
a GTP-binding protein in platelet activation also 
offers a possible explanation of the stimulation of 
platelet degranulation by F- [29]. The author in 
[21] has proposed that such a protein may directly 
regulate Ca2+ channels in mast cells. Thus, he 
found that incorporation of metabolically stable 
guanine nucleotides into permeabilized mast cells, 
which were then resealed, only stimulated secretion 
of histamine in the presence of extracellular Ca2+. 
However, this mechanism cannot account for the 
effects of these compounds on permeabilized 
platelets, which were equilibrated with Ca’+ buf- 
fers. A more plausible explanation is suggested by 
our finding that the action of thrombin alone, 
which closely resembled that of GTP, appears to 
be mediated by an enhanced formation of 
diacylglycerol and the subsequent activation of 
protein kinase C[17,19]. We therefore suggest hat 
a guanine nucleotide-binding protein may play a 
role in the receptor-mediated stimulation of 
phosphoinositide breakdown to diacylglycerol in 
platelets. This hypothesis is supported by the 
synergistic effects of GTP and stimulatory agonists 
and by preliminary results indicating that guanine 
nucleotides stimulate diacylglycerol formation in 
permeabilized platelets [171. This mechanism could 
also account for the results in [21], if another pro- 
duct of phosphoinositide metabolism, such as 
1,4,5-inositol trisphosphate, promoted Ca2+ entry 
into the mast cells. However, it is important to 
note that the failure of GDP@ to block the 
enhancement of Ca2’ sensitivity by agonists in the 
absence of added GTP, suggest hat an additional 
GTP-independent mechanism of receptor action 
exists in platelets. 
As also noted in [ lg], we found that low concen- 
trations of cyclic GMP can potentiate secretion of 
[‘4C]serotonin from permeabilized platelets, par- 
ticularly in the presence of thrombin. However, 
since the same concentrations of either GMP or 
GTP had very similar effects and the actions of all 
3 compounds were blocked by GDPPS, cyclic 
GMP probably acts through the formation of GTP 
within the permeabilized platelets, rather than by a 
specific cyclic GMP-dependent mechanism, as sug- 
gested in [ 181. As Gpp(NH)p and GTPyS are poor 
substrates for guanylate cyclase compared with 
GTP [30], cyclic GMP formation could not ac- 
Volume 174, number 1 FEBS LETTERS August 1984 
count for the relative activities of these compounds 
on permeabilized platelets. In any case, the 
available evidence [3 1,321 suggests that cyclic 
GMP has inhibitory rather than stimulatory effects 
in intact platelets. 
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